ClinicalTrials.gg
Sign In

Spinocerebellar Degenerations clinical trials

The registry lists 49 studies for Spinocerebellar Degenerations across more than 10 countries. 15 are recruiting or about to start. 29 of them are mainly about Spinocerebellar Degenerations (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 4 narrower conditions too, such as Friedreich Ataxia: 295 studies, 69 open.

Get an email when these change. Save the Spinocerebellar Degenerations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
24
Recruiting
9
Not yet recruiting
6
Active, not recruiting
5
Status unknown
2
Terminated
2

Phase

Phase 2
19
Phase 3
9
Phase 1
7
Phase 4
1

Where

United States
18
Japan
11
China
10
Spain
7
Italy
7
France
6

Who runs them

Kissei Pharmaceutical Co., Ltd. (9) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Second Affiliated Hospital, School of Medicine, Zhejiang University (3) · Universitat de Lleida (2) · Bristol-Myers Squibb (2) · Columbia University (2) · National Institute of Neurological Disorders and Stroke (NINDS) (2) · Merck Sharp & Dohme LLC (2)

What is being tested here

Drugs under test in Spinocerebellar Degenerations studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bevacizumab102
Iparomlimab/Tuvonralimab111
Xelox101
Porustobart101
Ipilimumab N01101
Sintilimab101
Ipilimumab101
Rovatirelin069
Nivolumab012
Pembrolizumab002

Drug classes tested here Immune checkpoint inhibitors 5 open

Coming up

3phase 3 studies under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 9 Spinocerebellar Degenerations studies recruiting now, 5 (56%) set no upper age limit and 3 (33%) stop at 75 or younger. 4 (44%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (11%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
104 (44%)4 (44%)
188 (89%)8 (89%)
309 (100%)9 (100%)
409 (100%)9 (100%)
509 (100%)9 (100%)
658 (89%)8 (89%)
756 (67%)6 (67%)
856 (67%)6 (67%)

Across all 49 studies, recruiting or not: 16% stop at 75 or younger and 12% at 65; 18% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 49 of 49. search them.